Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2016Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2016Q2 $ vs. 2016Q2
BeiGene, Ltd. DEPOSITORY RECEIPT 132,057 $4,069,000 0.26% New +$4,069,000
Mylan N.V. ON STOCK 94,711 $3,610,000 0.23% New +$3,610,000
INNOCOLL HOLDINGS PLC ON STOCK 547,792 $3,221,000 0.21% New +$3,221,000
AVEO PHARMACEUTICALS, INC. ON STOCK 3,108,808 $2,766,000 0.18% New +$2,766,000
IVERIC bio, Inc. US EQUITY OPTION CALL 600,000 $2,740,000 0.18% New +$2,740,000
Aptevo Therapeutics Inc. ON STOCK 988,133 $2,530,000 0.16% New +$2,530,000
PROTEON THERAPEUTICS INC ON STOCK 269,005 $2,510,000 0.16% New +$2,510,000
MGC Diagnostics Corp ON STOCK 329,733 $2,275,000 0.15% New +$2,275,000
Neos Therapeutics, Inc. ON STOCK 330,593 $2,175,000 0.14% New +$2,175,000
Cephalon Inc ON STOCK 339,727 $2,137,000 0.14% New +$2,137,000
ACADIA PHARMACEUTICALS INC ON STOCK 65,240 $2,075,000 0.13% New +$2,075,000
Affimed N.V. ON STOCK 734,301 $2,041,000 0.13% New +$2,041,000
Arno Therapeutics Inc ON STOCK 4,177,577 $1,963,000 0.13% New +$1,963,000
ABBOTT LABORATORIES ON STOCK 46,019 $1,946,000 0.13% New +$1,946,000
Eiger BioPharmaceuticals, Inc. ON STOCK 129,920 $1,739,000 0.11% New +$1,739,000
CHINA BIOLOGIC PRODUCTS INC ON STOCK 13,695 $1,705,000 0.11% New +$1,705,000
BIO-RAD LABORATORIES, INC. ON STOCK 10,000 $1,638,000 0.11% New +$1,638,000
MEDGENICS INC ON STOCK 293,460 $1,635,000 0.11% New +$1,635,000
VOCERA COMMUNICATIONS, INC. ON STOCK 94,236 $1,593,000 0.10% New +$1,593,000
Adynxx, Inc. ON STOCK 1,921,951 $1,537,000 0.10% New +$1,537,000
Vericel Corp ON STOCK 544,996 $1,526,000 0.10% New +$1,526,000
NEVRO CORP ON STOCK 11,746 $1,226,000 0.08% New +$1,226,000
NIVALIS THERAPEUTICS INC ON STOCK 122,275 $994,000 0.06% New +$994,000
BRAINSTORM CELL THERAPEUTICS INC. ON STOCK 400,000 $964,000 0.06% New +$964,000
ANTARES PHARMA, INC. ON STOCK 0 $912,000 0.06% New -$912,000